Literature DB >> 27477254

Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial.

Andrea Santamato, Francesco Panza, Angela Notarnicola, Gennaro Cassatella, Francesca Fortunato, Jula Laura de Sanctis, Giovanni Valeno, Patrick G Kehoe, Davide Seripa, Giancarlo Logroscino, Pietro Fiore, Maurizio Ranieri.   

Abstract

UNLABELLED: Study Design Single-blind randomized trial. Background Extracorporeal shockwave therapy (ESWT) has been shown to produce good results in the treatment of subacromial impingement syndrome (SAIS). The efficacy of a combined administration of ESWT and isokinetic exercise (IE) has not yet been studied. Objectives To evaluate the efficacy of focused ESWT combined with IE for the rotator cuff versus focused ESWT alone in the treatment of SAIS. The secondary objective was to assess the isokinetic torque recovery (external rotation at 210°/s, 180°/s, and 120°/s). Methods Thirty participants with SAIS were randomly assigned to a focused-ESWT group or focused ESWT-plus-IE group. Subjects of both groups received 3 treatment sessions of focused ESWT over a period of 10 days. Participants in the second group also received IE for 10 therapy sessions. Outcome measures were the Constant-Murley score (CMS), the visual analog scale (VAS), and isokinetic parameters (peak torque and total work calculated from 5 repetitions) measured with the isokinetic test. Subjects were assessed at baseline, 10 days after the last treatment session with focused ESWT, and after 2 months of follow-up. Results At 2 months posttreatment, participants in the focused ESWT-plus-IE group showed significantly less pain (focused-ESWT VAS, 3.4 ± 0.8 versus focused ESWT-plus-IE VAS, 1.5 ± 0.5; P<.001) and greater improvement in functionality (focused-ESWT CMS, 75.9 ± 6.7 versus focused ESWT-plus-IE CMS, 92.1 ± 6.3; P<.001) and muscle endurance than the subjects in the focused-ESWT group. Conclusion In subjects with SAIS, combined administration of focused ESWT and IE for the rotator cuff resulted in greater reduction of pain, as well as superior functional recovery and muscle endurance in the short to medium term, compared with ESWT alone. Level of evidence Therapy, 2b. TRIAL REGISTRATION: unregistered 2011 trial. J Orthop Sports Phys Ther 2016;46(9):714-725. Epub 5 Aug 2016. doi:10.2519/jospt.2016.4629.

Entities:  

Keywords:  Constant-Murley score; isokinetic parameters; muscle torque; physical therapy; rotator cuff tendinopathy; shoulder pain; visual analog scale

Mesh:

Year:  2016        PMID: 27477254     DOI: 10.2519/jospt.2016.4629

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  5 in total

1.  Comparison of photobiomodulation therapy and suprascapular nerve-pulsed radiofrequency in chronic shoulder pain: a randomized controlled, single-blind, clinical trial.

Authors:  Burcu Metin Ökmen; Korgün Ökmen
Journal:  Lasers Med Sci       Date:  2017-05-25       Impact factor: 3.161

Review 2.  Screening of the cervical spine in subacromial shoulder pain: A systematic review.

Authors:  Tom Walker; Emma Salt; Greg Lynch; Chris Littlewood
Journal:  Shoulder Elbow       Date:  2018-09-20

3.  Comparison of Kinesiotaping, Exercise and Subacromial Injection Treatments on Functionality and Life Quality in Shoulder Impingement Syndrome: A Randomized Controlled Study.

Authors:  Ozge Vergili; Birhan Oktas; Ibrahim Deniz Canbeyli
Journal:  Indian J Orthop       Date:  2020-06-11       Impact factor: 1.251

Review 4.  Combined extracorporeal shockwave therapy and exercise for the treatment of tendinopathy: A narrative review.

Authors:  Ian Burton
Journal:  Sports Med Health Sci       Date:  2021-11-11

5.  The effectiveness of extracorporeal shockwave treatment in subacromial impingement syndrome and its relation with acromion morphology.

Authors:  Esra Circi; Sibel Caglar Okur; Ozge Aksu; Erhan Mumcuoglu; Tolga Tuzuner; Nil Caglar
Journal:  Acta Orthop Traumatol Turc       Date:  2017-11-16       Impact factor: 1.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.